Albulescu R
Albulescu R
Inst. National de C-D Chimico-Farmaceutica
Verified email at
Cited by
Cited by
Cytokine patterns in brain tumour progression
R Albulescu, E Codrici, ID Popescu, S Mihai, LG Necula, D Petrescu, ...
Mediators of inflammation 2013 (1), 979748, 2013
In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors
M Chivu, SO Dima, CI Stancu, C Dobrea, V Uscatescu, LG Necula, ...
Translational Research 154 (3), 122-132, 2009
The secretome of myocardial telocytes modulates the activity of cardiac stem cells
R Albulescu, C Tanase, E Codrici, DI Popescu, SM Cretoiu, LM Popescu
Journal of Cellular and Molecular Medicine 19 (8), 1783-1794, 2015
An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma
SO Dima, C Tanase, R Albulescu, V Herlea, M Chivu-Economescu, ...
Pancreas 41 (7), 1001-1007, 2012
Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
CP Tanase, E Codrici, ID Popescu, S Mihai, AM Enciu, LG Necula, ...
Oncotarget 8 (11), 18497, 2017
Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics
CP Tanase, AI Neagu, LG Necula, C Mambet, AM Enciu, B Calenic, ...
World journal of gastroenterology: WJG 20 (31), 10790, 2014
Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches
ID Popescu, E Codrici, L Albulescu, S Mihai, AM Enciu, R Albulescu, ...
Proteome science 12, 1-14, 2014
Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers
R Albulescu, M Neagu, L Albulescu, C Tanase
Expert review of molecular diagnostics 11 (1), 101-120, 2011
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
R Albulescu
Biomarkers in medicine 7 (2), 203-203, 2013
Beneficial effects of food supplements based on hydrolyzed collagen for skin care
MA Lupu, G Gradisteanu Pircalabioru, MC Chifiriuc, R Albulescu, ...
Experimental and therapeutic medicine 20 (1), 12-17, 2020
Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca
AA Motaal, H El-Askary, S Crockett, O Kunert, B Sakr, S Shaker, A Grigore, ...
Phytomedicine 22 (9), 829-836, 2015
Application of 3D hydrogel microarrays in molecular diagnostics: Advantages and limitations
CP Tanase, R Albulescu, M Neagu
Expert Review of Molecular Diagnostics 11 (5), 461-464, 2011
Advances in pancreatic cancer detection
CP Tanase, M Neagu, R Albulescu, ME Hinescu
Adv Clin Chem 51, 145-180, 2010
Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma
C Tanase, R Albulescu, E Codrici, B Calenic, ID Popescu, S Mihai, ...
OncoTargets and therapy, 81-90, 2014
Proteomic biomarkers panel: new insights in chronic kidney disease
S Mihai, E Codrici, ID Popescu, AM Enciu, E Rusu, D Zilisteanu, ...
Disease Markers 2016 (1), 3185232, 2016
Key signaling molecules in pituitary tumors
CP Tanase, M Neagu, R Albulescu
Expert Review of Molecular Diagnostics 9 (8), 859-877, 2009
Signal transduction molecule patterns indicating potential glioblastoma therapy approaches
ML Cruceru, AM Enciu, AC Popa, R Albulescu, M Neagu, CP Tanase, ...
OncoTargets and therapy, 1737-1749, 2013
Caveolin‐1‐Knockout Mouse as a Model of Inflammatory Diseases
E Codrici, L Albulescu, ID Popescu, S Mihai, AM Enciu, R Albulescu, ...
Journal of immunology research 2018 (1), 2498576, 2018
Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro
E Codorean, C Nichita, L Albulescu, E Răducan, ID Popescu, AC Lonita, ...
Roum Arch Microbiol Immunol 69 (1), 13-19, 2010
CD36 and CD97 in pancreatic cancer versus other malignancies
C Tanase, AA Gheorghisan-Galateanu, ID Popescu, S Mihai, E Codrici, ...
International journal of molecular sciences 21 (16), 5656, 2020
The system can't perform the operation now. Try again later.
Articles 1–20